CRISPR Therapeutics AG Insider Trading for December 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CRISPR Therapeutics AG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CRISPR Therapeutics AG for December 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 27 2017 | CRSP | CRISPR Therapeutic ... | Dylan-Hyde Tyler | Chief Legal Officer | Sell | S | 20.55 | 15,000 | 308,250 | 115,204 | 130.2 K to 115.2 K (-11.52 %) |
Dec 27 2017 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Sell | S | 20.30 | 26,016 | 528,237 | 27,724 | 53.7 K to 27.7 K (-48.41 %) |
Dec 27 2017 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Sell | S | 20.29 | 3,059 | 62,070 | 4,959 | 8 K to 5 K (-38.15 %) |
Dec 26 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Option Exercise | M | 1.81 | 15,000 | 27,150 | 279,558 | |
Dec 26 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Buy | M | 1.81 | 15,000 | 27,150 | 148,560 | 133.6 K to 148.6 K (+11.23 %) |
Dec 19 2017 | CRSP | CRISPR Therapeutic ... | Dylan-Hyde Tyler | Chief Legal Officer | Sell | S | 18.90 | 15,000 | 283,496 | 130,204 | 145.2 K to 130.2 K (-10.33 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.47 | 30,485 | 593,543 | 3,722,534 | 3.8 M to 3.7 M (-0.81 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.10 | 87,991 | 1,680,628 | 3,753,019 | 3.8 M to 3.8 M (-2.29 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.04 | 12,666 | 241,161 | 3,841,010 | 3.9 M to 3.8 M (-0.33 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.25 | 4,263 | 82,063 | 3,853,676 | 3.9 M to 3.9 M (-0.11 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.22 | 5,080 | 97,638 | 3,857,939 | 3.9 M to 3.9 M (-0.13 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.75 | 27,990 | 552,803 | 3,863,019 | 3.9 M to 3.9 M (-0.72 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 20.00 | 26,010 | 520,200 | 3,891,009 | 3.9 M to 3.9 M (-0.66 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.76 | 256,000 | 5,058,560 | 3,917,019 | 4.2 M to 3.9 M (-6.13 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.25 | 80,000 | 1,540,000 | 4,173,019 | 4.3 M to 4.2 M (-1.88 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.02 | 158,718 | 3,018,816 | 4,253,019 | 4.4 M to 4.3 M (-3.60 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.44 | 51,282 | 945,640 | 4,411,737 | 4.5 M to 4.4 M (-1.15 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.39 | 105,000 | 1,930,950 | 4,463,019 | 4.6 M to 4.5 M (-2.30 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.67 | 15,000 | 265,050 | 4,568,019 | 4.6 M to 4.6 M (-0.33 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.19 | 14,907 | 256,251 | 4,583,019 | 4.6 M to 4.6 M (-0.32 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.76 | 65,093 | 1,156,052 | 4,597,926 | 4.7 M to 4.6 M (-1.40 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.28 | 10,000 | 172,800 | 4,663,019 | 4.7 M to 4.7 M (-0.21 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 17.08 | 20,000 | 341,600 | 4,673,019 | 4.7 M to 4.7 M (-0.43 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.06 | 16,875 | 304,763 | 4,693,019 | 4.7 M to 4.7 M (-0.36 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.54 | 23,000 | 426,420 | 4,709,894 | 4.7 M to 4.7 M (-0.49 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 18.89 | 79,327 | 1,498,487 | 4,732,894 | 4.8 M to 4.7 M (-1.65 %) |
Dec 07 2017 | CRSP | CRISPR Therapeutic ... | CELGENE CORP /DE/ | 10% Owner | Sell | S | 19.10 | 22,759 | 434,697 | 4,812,221 | 4.8 M to 4.8 M (-0.47 %) |
Dec 05 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Option Exercise | A | 19.12 | 260,000 | 4,971,200 | 260,000 | |
Dec 05 2017 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Grant | A | 19.12 | 26,667 | 509,873 | 133,560 | 106.9 K to 133.6 K (+24.95 %) |